aTYR PHARMA INC financial data

Symbol
ATYR on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 608 % -3.2%
Return On Equity -100 % -26.3%
Return On Assets -74.7 % -26.3%
Operating Margin -41.4K % -42.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 98M shares +16.7%
Common Stock, Shares, Outstanding 98M shares +29.3%
Entity Public Float 116M USD -3.75%
Common Stock, Value, Issued 98K USD +28.9%
Weighted Average Number of Shares Outstanding, Basic 97.2M shares +28.2%
Weighted Average Number of Shares Outstanding, Diluted 97.2M shares +28.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 190K USD -19.1%
Research and Development Expense 61.6M USD +12.1%
General and Administrative Expense 17.3M USD +29.1%
Operating Income (Loss) -78.7M USD -15.6%
Nonoperating Income (Expense) 3.52M USD -16.8%
Net Income (Loss) Attributable to Parent -75.1M USD -17.7%
Earnings Per Share, Basic 0 USD/shares +10.9%
Earnings Per Share, Diluted 0 USD/shares +10.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.15M USD -46.3%
Assets, Current 93M USD +21.9%
Property, Plant and Equipment, Net 4.43M USD -11.8%
Operating Lease, Right-of-Use Asset 5.6M USD -4.73%
Other Assets, Noncurrent 149K USD +14.6%
Assets 107M USD +16.4%
Accounts Payable, Current 4.06M USD +2.91%
Employee-related Liabilities, Current 3.09M USD +14.3%
Accrued Liabilities, Current 10.2M USD +13.7%
Liabilities, Current 15.7M USD +11.1%
Operating Lease, Liability, Noncurrent 10.5M USD -7.05%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD -103%
Retained Earnings (Accumulated Deficit) -592M USD -14.5%
Stockholders' Equity Attributable to Parent 80.2M USD +22.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 80M USD +22.9%
Liabilities and Equity 107M USD +16.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.4M USD +31.1%
Net Cash Provided by (Used in) Financing Activities 18.6M USD +141%
Net Cash Provided by (Used in) Investing Activities -4.42M USD -226%
Common Stock, Shares Authorized 170M shares 0%
Common Stock, Shares, Issued 98M shares +29.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.21M USD +92.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 28K USD -26.3%
Deferred Tax Assets, Valuation Allowance 124M USD +15%
Deferred Tax Assets, Gross 125M USD +14.6%
Operating Lease, Liability 11.3M USD -5.69%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -75.2M USD -18.4%
Property, Plant and Equipment, Gross 9.39M USD -7.49%
Operating Lease, Liability, Current 799K USD +17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.92M USD +7.64%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.78M USD +3.37%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.64M USD -12.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.98M USD +3.08%
Deferred Tax Assets, Operating Loss Carryforwards 68.8M USD +14.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 36.8M USD +22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.98M USD +1.7%
Additional Paid in Capital 672M USD +15.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 167K USD -6.18%
Deferred Tax Assets, Net of Valuation Allowance 1.22M USD -13.5%
Share-based Payment Arrangement, Expense 4.56M USD +58.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%